National Center for Health Statistics, ICD-10 Coordination and Maintenance Committee, 49465-49466 [2023-16105]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 145 / Monday, July 31, 2023 / Notices
Nominations may be submitted by the
candidate or by the person/organization
recommending the candidate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–16102 Filed 7–28–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Health Statistics,
ICD–10 Coordination and Maintenance
Committee
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), National
Center for Health Statistics (NCHS),
Classifications and Public Health Data
Standards Staff, announces the
following meeting of the ICD–10
Coordination and Maintenance (C&M)
Committee. This meeting is open to the
public, limited only by the number of
audio lines available. Online
Registration is required.
DATES: The meeting will be held on
September 12, 2023, from 9 a.m. to 5
p.m., EDT, and September 13, 2023,
from 9 a.m. to 5 p.m., EDT.
ADDRESSES: This is a virtual meeting.
Register in advance at https://
cms.zoomgov.com/webinar/register/
WN_lWLKuwKzQU6iJdvcDvXhdA. After
registering, you will receive a
confirmation email containing
information about joining the meeting.
Further information will be provided on
each of the respective web pages when
it becomes available. For CDC, NCHS:
https://www.cdc.gov/nchs/icd/icd10cm_
maintenance.htm. For the Centers for
Medicare & Medicaid Services,
Department of Health and Human
Services: https://www.cms.gov/
Medicare/Coding/ICD10/C-and-MMeeting-Materials.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:11 Jul 28, 2023
Jkt 259001
FOR FURTHER INFORMATION CONTACT:
Traci Ramirez, Medical Classification
Specialist, National Center for Health
Statistics, Centers for Disease Control
and Prevention, 3311 Toledo Road,
Hyattsville, Maryland 20782–2064.
Telephone: (301) 458–4454; Email:
TRamirez@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The ICD–10 Coordination
and Maintenance (C&M) Committee is a
public forum for the presentation of
proposed modifications to the
International Classification of Diseases,
Tenth Revision, Clinical Modification
(CM) and ICD–10 Procedure Coding
System (PCS).
Matters to be Considered: The
tentative agenda will include
discussions on the ICD–10–CM and
ICD–10–PCS topics listed below.
Agenda items are subject to change as
priorities dictate. Please refer to the
posted agenda for updates one month
prior to the meeting.
ICD–10–PCS Topics:
1. Administration of Iodine (131I)
Apamistamab **
2. Irreversible Electroporation for
Cardiac Ablation **
3. Computer-aided Anesthesia and
Oxygen Delivery System ***
4. Sub-epidermal Moisture Sensor **
5. Insertion of Palladium-103
Radioactive Implant *
6. Implantation of Bone Void Filler ***
7. Section X Updates
8. Addenda and Key Updates *
* Request is for an April 1, 2024,
implementation date.
** Request is for an April 1, 2024,
implementation date, and the requestor
intends to submit a new technology
add-on payment (NTAP) application for
FY 2025 consideration.
*** Requestor intends to submit an
NTAP application for FY 2025
consideration.
Presentations for procedure code
requests are conducted by both the
requestor and the Centers for Medicare
& Medicaid Services (CMS) during the
C&M Committee meeting. Discussion
from the requestor generally focuses on
the clinical issues for the procedure or
technology, followed by the proposed
coding options from a CMS analyst.
Topics presented may also include
requests for new procedure codes that
relate to a new technology add-on
payment (NTAP) policy request.
CMS has modified the approach for
presenting the new NTAP-related ICD–
10–PCS procedure code requests that
involve the administration of a
therapeutic agent. For the September
12–13, 2023, ICD–10 C&M Committee
meeting, consistent with the
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
49465
requirements of section
1886(d)(5)(K)(iii) of the Social Security
Act, applicants submitted requests to
create a unique procedure code to
describe the administration of a
therapeutic agent, such as the option to
create a new code in Section X within
the ICD–10–PCS procedure code
classification. CMS will initially display
only those meeting materials associated
with the NTAP-related ICD–10–PCS
procedure code requests that involve the
administration of a therapeutic agent on
the CMS website in August 2023 at:
https://www.cms.gov/Medicare/Coding/
ICD10/C-and-M-Meeting-Materials.
The NTAP-related ICD–10–PCS
procedure code request that involves the
administration of a therapeutic agent is:
Administration of Iodine (131I)
Apamistamab **
** Request is for an April 1, 2024,
implementation date, and the requestor
intends to submit an NTAP application
for FY 2025 consideration.
This topic will not be presented
during the September 12–13, 2023,
meeting. CMS will solicit public
comments regarding any clinical
questions or coding options included for
this procedure code topic in advance of
the meeting continuing through the end
of the respective public comment
periods. Members of the public should
send any questions or comments to the
CMS mailbox at:
ICDProcedureCodeRequest@
cms.hhs.gov.
CMS intends to post a question-andanswer document in advance of the
meeting to address any clinical or
coding questions that members of the
public may have submitted. Following
the conclusion of the meeting, CMS will
post an updated question-and-answer
document to address any additional
clinical or coding questions that
members of the public may have
submitted during the meeting that CMS
was not able to address or that were
submitted after the meeting.
The NTAP-related ICD–10–PCS
procedure code requests that do not
involve the administration of a
therapeutic agent and all non-NTAPrelated procedure code requests will
continue to be presented during the
virtual meeting on September 12, 2023,
consistent with the standard meeting
process.
CMS will make all meeting materials
and related documents available at:
https://www.cms.gov/Medicare/Coding/
ICD10/C-and-M-Meeting-Materials. Any
inquiries related to the procedure code
topics scheduled for the September 12–
13, 2023, ICD–10 C&M Committee
meeting that are under consideration for
E:\FR\FM\31JYN1.SGM
31JYN1
49466
Federal Register / Vol. 88, No. 145 / Monday, July 31, 2023 / Notices
April 1, 2024, or October 1, 2024,
implementation should be sent to the
CMS mailbox at:
ICDProcedureCodeRequest@
cms.hhs.gov.
ICD–10–CM Topics:
1. Abnormal Anti-cyclic Citrullinated
Peptide Antibody and/or
Rheumatoid Factor Without Current
or Prior Clinical Diagnosis of
Rheumatoid Arthritis
2. Adverse Effects of Immune
Checkpoint Therapy
3. Anal Fistula
4. Baked Egg Tolerance
5. Baked Milk Tolerance
6. Duffy Phenotype
7. Flank Anatomical Specificity
8. Gulf War Illness
9. Hyperoxaluria
10. Injection Drug Use
11. Lymphoma in Remission
12. Post-exertional Malaise
13. Usher Syndrome
14. Addenda
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–16105 Filed 7–28–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–9893–N]
Meeting Date for Ground Ambulance
and Patient Billing (GAPB) Advisory
Committee—August 16, 2023
Centers for Medicare &
Medicaid Services (CMS), Department
of Health and Human Services (HHS).
ACTION: Notice of meeting.
ddrumheller on DSK120RN23PROD with NOTICES1
AGENCY:
This notice announces the
second public meeting of the Ground
Ambulance and Patient Billing (GAPB)
Advisory Committee on August 16,
2023. The GAPB Advisory Committee
will make recommendations with
respect to the disclosure of charges and
fees for ground ambulance services and
SUMMARY:
VerDate Sep<11>2014
18:11 Jul 28, 2023
Jkt 259001
insurance coverage, consumer
protection and enforcement authorities
of the Departments of Labor, Health and
Human Services, and the Treasury (the
Departments) and relevant States, and
the prevention of balance billing to
consumers. The recommendations will
address options, best practices, and
identified standards to prevent
instances of balance billing; steps that
can be taken by State legislatures, State
insurance regulators, State attorneys
general, and other State officials as
appropriate, consistent with current
legal authorities regarding consumer
protection; and, legislative options for
Congress to prevent balance billing.
DATES:
Virtual Meeting Date: The GAPB
Advisory Committee will hold a virtual
meeting on Wednesday, August 16,
2023, from 9:30 a.m. to 5:30 p.m.,
Eastern Daylight Time.
Registration Link: The virtual meeting
will be open to the public and held via
the Zoom webinar platform. Virtual
attendance information will be provided
upon registration. To register for this
virtual meeting visit: https://
priforum.zoomgov.com/webinar/
register/WN_fRPS8zNkQbOl1GZux_MeA. Attendance is open to the public
subject to any technical or capacity
limitations.
Deadline for Registration: All
individuals who plan to attend the
virtual public meeting must register to
attend. The deadline to register for the
public meeting is Tuesday, August 15,
2023. Interested parties are encouraged
to register as far in advance of the
meeting as possible. A detailed agenda
and materials will be available prior to
the meeting on the GAPB Advisory
Committee website at: https://
www.cms.gov/regulations-guidance/
advisory-committees/advisorycommittee-ground-ambulance-andpatient-billing-gapb.
A recording and a summary of the
meeting will be made available on the
GAPB Advisory Committee website
within 45 calendar days after the
meeting.
Virtual Meeting Location:
The August 16, 2023, public meeting
will be held virtually via Zoom only.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Shaheen Halim, CMS, by phone (410)
786–0641 or via email at
gapbadvisorycommittee@cms.hhs.gov.
Press inquiries may be submitted by
phone at (202) 690–6145 or via email at
press@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
I. Background
Section 117(a) of the No Surprises
Act, enacted as part of the Consolidated
Appropriations Act, 2021, div. BB, tit. I,
Public Law 116–260 (Dec. 27, 2020),
requires the Secretaries of the
Departments of Labor, the Department
of Health and Human Services (HHS),
and the Treasury (collectively, the
Departments) to establish and convene
an advisory committee for the purpose
of reviewing options to improve the
disclosure of charges and fees for
ground ambulance services, better
inform consumers of insurance options
for such services, and protect consumers
from balance billing. The GAPB
Advisory Committee is governed by the
provisions of the Federal Advisory
Committee Act (FACA), Public Law 92–
463 (Oct. 6, 1972), as amended, 5 U.S.C.
app. 2. The GAPB Advisory Committee
held its first meeting on May 2, 2023
and May 3, 2023. Information on past
and current Committee activity can be
found at: https://www.cms.gov/
regulations-guidance/advisorycommittees/advisory-committee-groundambulance-and-patient-billing-gapb.
II. Advisory Committee Membership
Roster
On November 23, 2021, HHS
published a Notice of Charter and
Invitation for Member Nominations in
the Federal Register for the GAPB
Advisory Committee (86 FR 66565
through 66566). The Departments
evaluated the nominees for alignment
with the membership categories
required under section 117 of the No
Surprises Act, their professional
qualifications, recognition by the
ground ambulance and emergency
medical services community, years of
relevant experience, experience with
State or Federal committees on related
issues, and expertise in subject matter to
be addressed by the committee. The
Departments also considered
membership balance as required by the
FACA, and as appropriate to address
health equity issues pertaining to
ground ambulance consumer balance
billing, and ground ambulance services
in underserved communities. On
December 16, 2022, HHS published a
Federal Register notice, announcing the
17 Members of the GAPB Advisory
Committee (87 FR 77122 through
77123). A subsequent update to the
Committee Roster was published on
April 14, 2023 (88 FR 23046).
The 17 Members of the GAPB
Advisory Committee are as follows:
• Asbel Montes—Committee
Chairperson; Additional Representative
E:\FR\FM\31JYN1.SGM
31JYN1
]]>Agencies
[Federal Register Volume 88, Number 145 (Monday, July 31, 2023)]
[Notices]
[Pages 49465-49466]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-16105]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Center for Health Statistics, ICD-10 Coordination and
Maintenance Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), National
Center for Health Statistics (NCHS), Classifications and Public Health
Data Standards Staff, announces the following meeting of the ICD-10
Coordination and Maintenance (C&M) Committee. This meeting is open to
the public, limited only by the number of audio lines available. Online
Registration is required.
DATES: The meeting will be held on September 12, 2023, from 9 a.m. to 5
p.m., EDT, and September 13, 2023, from 9 a.m. to 5 p.m., EDT.
ADDRESSES: This is a virtual meeting. Register in advance at https://cms.zoomgov.com/webinar/register/WN_lWLKuwKzQU6iJdvcDvXhdA. After
registering, you will receive a confirmation email containing
information about joining the meeting. Further information will be
provided on each of the respective web pages when it becomes available.
For CDC, NCHS: https://www.cdc.gov/nchs/icd/icd10cm_maintenance.htm.
For the Centers for Medicare & Medicaid Services, Department of Health
and Human Services: https://www.cms.gov/Medicare/Coding/ICD10/C-and-M-Meeting-Materials.
FOR FURTHER INFORMATION CONTACT: Traci Ramirez, Medical Classification
Specialist, National Center for Health Statistics, Centers for Disease
Control and Prevention, 3311 Toledo Road, Hyattsville, Maryland 20782-
2064. Telephone: (301) 458-4454; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The ICD-10 Coordination and Maintenance (C&M) Committee is
a public forum for the presentation of proposed modifications to the
International Classification of Diseases, Tenth Revision, Clinical
Modification (CM) and ICD-10 Procedure Coding System (PCS).
Matters to be Considered: The tentative agenda will include
discussions on the ICD-10-CM and ICD-10-PCS topics listed below. Agenda
items are subject to change as priorities dictate. Please refer to the
posted agenda for updates one month prior to the meeting.
ICD-10-PCS Topics:
1. Administration of Iodine (131I) Apamistamab **
2. Irreversible Electroporation for Cardiac Ablation **
3. Computer-aided Anesthesia and Oxygen Delivery System ***
4. Sub-epidermal Moisture Sensor **
5. Insertion of Palladium-103 Radioactive Implant *
6. Implantation of Bone Void Filler ***
7. Section X Updates
8. Addenda and Key Updates *
* Request is for an April 1, 2024, implementation date.
** Request is for an April 1, 2024, implementation date, and the
requestor intends to submit a new technology add-on payment (NTAP)
application for FY 2025 consideration.
*** Requestor intends to submit an NTAP application for FY 2025
consideration.
Presentations for procedure code requests are conducted by both the
requestor and the Centers for Medicare & Medicaid Services (CMS) during
the C&M Committee meeting. Discussion from the requestor generally
focuses on the clinical issues for the procedure or technology,
followed by the proposed coding options from a CMS analyst. Topics
presented may also include requests for new procedure codes that relate
to a new technology add-on payment (NTAP) policy request.
CMS has modified the approach for presenting the new NTAP-related
ICD-10-PCS procedure code requests that involve the administration of a
therapeutic agent. For the September 12-13, 2023, ICD-10 C&M Committee
meeting, consistent with the requirements of section 1886(d)(5)(K)(iii)
of the Social Security Act, applicants submitted requests to create a
unique procedure code to describe the administration of a therapeutic
agent, such as the option to create a new code in Section X within the
ICD-10-PCS procedure code classification. CMS will initially display
only those meeting materials associated with the NTAP-related ICD-10-
PCS procedure code requests that involve the administration of a
therapeutic agent on the CMS website in August 2023 at: https://www.cms.gov/Medicare/Coding/ICD10/C-and-M-Meeting-Materials.
The NTAP-related ICD-10-PCS procedure code request that involves
the administration of a therapeutic agent is:
Administration of Iodine (131I) Apamistamab **
** Request is for an April 1, 2024, implementation date, and the
requestor intends to submit an NTAP application for FY 2025
consideration.
This topic will not be presented during the September 12-13, 2023,
meeting. CMS will solicit public comments regarding any clinical
questions or coding options included for this procedure code topic in
advance of the meeting continuing through the end of the respective
public comment periods. Members of the public should send any questions
or comments to the CMS mailbox at: [email protected].
CMS intends to post a question-and-answer document in advance of
the meeting to address any clinical or coding questions that members of
the public may have submitted. Following the conclusion of the meeting,
CMS will post an updated question-and-answer document to address any
additional clinical or coding questions that members of the public may
have submitted during the meeting that CMS was not able to address or
that were submitted after the meeting.
The NTAP-related ICD-10-PCS procedure code requests that do not
involve the administration of a therapeutic agent and all non-NTAP-
related procedure code requests will continue to be presented during
the virtual meeting on September 12, 2023, consistent with the standard
meeting process.
CMS will make all meeting materials and related documents available
at: https://www.cms.gov/Medicare/Coding/ICD10/C-and-M-Meeting-Materials. Any inquiries related to the procedure code topics scheduled
for the September 12-13, 2023, ICD-10 C&M Committee meeting that are
under consideration for
[[Page 49466]]
April 1, 2024, or October 1, 2024, implementation should be sent to the
CMS mailbox at: [email protected].
ICD-10-CM Topics:
1. Abnormal Anti-cyclic Citrullinated Peptide Antibody and/or
Rheumatoid Factor Without Current or Prior Clinical Diagnosis of
Rheumatoid Arthritis
2. Adverse Effects of Immune Checkpoint Therapy
3. Anal Fistula
4. Baked Egg Tolerance
5. Baked Milk Tolerance
6. Duffy Phenotype
7. Flank Anatomical Specificity
8. Gulf War Illness
9. Hyperoxaluria
10. Injection Drug Use
11. Lymphoma in Remission
12. Post-exertional Malaise
13. Usher Syndrome
14. Addenda
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-16105 Filed 7-28-23; 8:45 am]
BILLING CODE 4163-18-P
